We are live on ! Find out more
MESO

Mesoblast

23 hedge funds and large institutions have $13.6M invested in Mesoblast in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more capital invested

Capital invested by funds: $11M → $13.6M (+$2.59M)

0.01% less ownership

Funds ownership: 0.27%0.26% (-0.01%)

17% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 6

18% less funds holding

Funds holding: 2823 (-5)

71% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 7

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $81K

Holders
23
Holders Change
-5
Holders Change %
-17.86%
% of All Funds
0.5%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
5
Reduced
6
Closed
7
Calls
Puts
$81K
Net Calls
-$81K
Net Calls Change
-$82K
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
26
UBS Group
Switzerland
-$3K -413 Closed
Barclays
27
Barclays
United Kingdom
-$1K -76 Closed

MESO Hedge Fund Activity: Q1 2019 in Review

23 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q1 2019, worth a combined $13.6M — up 23% from $11M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of MESO and 2 opened new positions — a net loss of 5 holders — while 6 trimmed existing stakes and 5 added.

The largest buyer was Renaissance Technologies, adding an estimated $281K. The largest seller was Jane Street, cutting an estimated $408K.

  • 23 institutional investors held Mesoblast (MESO) as of Q1 2019, down from 28 in Q4 2018.
  • Funds reported $13.6M of Mesoblast stock for Q1 2019, up 23% quarter-over-quarter.
  • 2 funds opened new Mesoblast positions in Q1 2019 and 7 closed out, a net change of -5 holders.
  • The largest Mesoblast buyer in Q1 2019 was Renaissance Technologies, an estimated $281K added.
  • The largest Mesoblast seller in Q1 2019 was Jane Street, an estimated $408K sold.

Based on aggregated 13F filings for Q1 2019.